Indigo Diabetes SA

11.1 FTE

Indigo Diabetes reported revenue of 1,523 € for the 2025 financial year (annual accounts filed with the NBB on 21 May 2026), with 11.1 full-time equivalents.

By total assets for 2025, Indigo Diabetes ranks among the 50 largest of the 684 companies in its sector (NACE 3250) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0666.442.557 · VAT BE0666442557
9052 Ghent
active in Manufacture of medical and dental instruments and supplies (NACE 32500)
operating since 17 Nov 2016 (≈ 10 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Indigo Diabetes shows with a free account.

See the score
Profile
SA Small · 11.1 FTE since 2016
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue1,523 €
Net result−€5.20m
Equity−€1.74m
Cash€2.54m
EBITDA−€2.94m
Total assets€5.01m
Headcount (avg FTE)11.1
Solvency-34.7%
The line marks its sector median: 52.2% (404 companies).

Change 2022 → 2025: Total assets -69 % Headcount (avg FTE) -66 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Indigo Diabetes's annual accounts

20252024202320222021
Revenue1,523 €
Net result−€5.20m
Equity−€1.74m
Cash€2.54m
EBITDA−€2.94m
Total assets€5.01m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 21 May 2026
  • Year ended 31 Dec 2024filed on 23 Apr 2025
  • Year ended 31 Dec 2023filed on 15 May 2024
  • Year ended 31 Dec 2022filed on 23 May 2023
  • Year ended 31 Dec 2021filed on 05 Aug 2022

Indigo Diabetes's financial analysis

Management and control of Indigo Diabetes

9 active director(s) in the register.

and 3 more

Indigo Diabetes's shareholders and holdings →

Indigo Diabetes's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0666.442.557
VAT number
BE0666442557
Peppol
Registered · 0208:0666442557 · as of 10 Nov 2026
Legal form
SA
Incorporated
17 Nov 2016
Registered office
9052 Ghent
Size
Small · 11.1 FTE
Latest accounts
2025 · filed on 21 May 2026
Activity
Manufacture of medical and dental instruments and supplies (NACE 32500)

Indigo Diabetes (SA) has been based in Ghent since 2016, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports revenue of 1,523 €, a net loss of €5.20m and equity of −€1.74m. With 11.1 full-time equivalents, it is a small enterprise by headcount.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Indigo Diabetes

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Indigo Diabetes

What is the revenue of Indigo Diabetes?

According to the 2025 annual accounts filed with the NBB, the revenue of Indigo Diabetes amounts to 1,523 €.

What is the VAT number of Indigo Diabetes?

In Belgium, the VAT number is the company number prefixed with BE: BE0666442557 for Indigo Diabetes, if the company is VAT-registered. Its company number (CBE) is 0666.442.557.

Where is the registered office of Indigo Diabetes?

According to the CBE register, the registered office of Indigo Diabetes is in 9052 Ghent.

What is the equity of Indigo Diabetes?

At the close of the 2025 financial year, the equity of Indigo Diabetes amounts to -1,737,695 €, a solvency of -34.7% of total assets.

How many people work at Indigo Diabetes?

11.1 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Indigo Diabetes?

The register lists 9 active mandates at Indigo Diabetes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Indigo Diabetes within its sector?

By total assets for 2025, Indigo Diabetes ranks among the 50 largest of the 684 companies in its sector (NACE 3250) in Belgium that filed accounts for that financial year.

Idonis

The full file of Indigo Diabetes

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 24 Jul 2026

No credit card, no commitment.

What each plan unlocks →